A new trial, not yet open to recruitment will test the combination of CBT-1, a drug developed to reverse multi-drug resistance, and Doxorubicin:
More about CBT-1:
http://cbapharma.com/CBT1/cbt1.html
A new trial, not yet open to recruitment will test the combination of CBT-1, a drug developed to reverse multi-drug resistance, and Doxorubicin:
More about CBT-1:
http://cbapharma.com/CBT1/cbt1.html